Although the evidence of neuropathic pain with NGF is obvious, there are still trials for NGF treatment because it has great pharmacological potential for the treatment of central neurodegenerative diseases and for peripheral neuropathies [2]. The gene discussed is NGF; the disease is peripheral neuropathy.